ArticlebioRxiv : the preprint server for biology2025

A patient-derived ovarian cancer organoid platform to study susceptibility to natural killer cells.

Marisa Mercadante et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.